Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Aptevo Therapeutics Inc (APVO)
NASDAQ:APVO
Aptevo Therapeutics (APVO) Stock Price & Analysis
291 Followers
APVO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.53 - $7.20
Previous Close$1.65
Volume34.55K
Average Volume (3M)52.28K
Market Cap
$11.96M
Enterprise Value-$7.40M
Total Cash (Recent Filing)$25.33M
Total Debt (Recent Filing)$5.90M
Price to Earnings (P/E)0.4
Beta1.39
Next Earnings
Aug 10, 2023EPS Estimate
-$1.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)3.75
Shares Outstanding7,290,121
10 Day Avg. Volume46,218
30 Day Avg. Volume52,278
Standard Deviation0.78
R-Squared0.14
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)1.44
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)0.70
P/FCF Ratio0.70
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-2.38
Enterprise Value/Ebitda0.41
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Aptevo Therapeutics News
Pre-EarningsAPVO Upcoming Earnings Report: What to Expect?
Pre-EarningsAptevo (APVO) Q4 Earnings Cheat Sheet
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
APVO FAQ
What was Aptevo Therapeutics Inc’s price range in the past 12 months?
Aptevo Therapeutics Inc lowest stock price was $1.53 and its highest was $7.20 in the past 12 months.
What is Aptevo Therapeutics Inc’s market cap?
Currently, no data Available
When is Aptevo Therapeutics Inc’s upcoming earnings report date?
Aptevo Therapeutics Inc’s upcoming earnings report date is Aug 10, 2023 which is in 71 days.
How were Aptevo Therapeutics Inc’s earnings last quarter?
Aptevo Therapeutics Inc released its earnings results on May 11, 2023. The company reported $0.26 earnings per share for the quarter, beating the consensus estimate of -$1.185 by $1.445.
Is Aptevo Therapeutics Inc overvalued?
According to Wall Street analysts Aptevo Therapeutics Inc’s price is currently Overvalued.
Does Aptevo Therapeutics Inc pay dividends?
Aptevo Therapeutics Inc does not currently pay dividends.
What is Aptevo Therapeutics Inc’s EPS estimate?
Aptevo Therapeutics Inc’s EPS estimate is -$1.12.
How many shares outstanding does Aptevo Therapeutics Inc have?
Aptevo Therapeutics Inc has 7,290,121 shares outstanding.
What happened to Aptevo Therapeutics Inc’s price movement after its last earnings report?
Aptevo Therapeutics Inc reported an EPS of $0.26 in its last earnings report, beating expectations of -$1.185. Following the earnings report the stock price went down -2.312%.
Which hedge fund is a major shareholder of Aptevo Therapeutics Inc?
Currently, no hedge funds are holding shares in APVO
---
Aptevo Therapeutics Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-64.89%
12-Months-Change
Fundamentals
Return on Equity
192.45%
Trailing 12-Months
Asset Growth
-22.61%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Aptevo Therapeutics Inc
Aptevo Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, commercialization and sale of novel oncology and hematology therapeutics to improve patients lives. Its pipeline includes APVO210, APVO436, ROR1 Candidate, and ALG.APV-527. The company was founded on February 22, 2016 and is headquartered in Seattle, WA.
---
Top 5 ETFs holding APVO
iShares Core S&P Total U.S. Stock Market ETF
$1.70K
Up to five ETFs with an Outperform Smart Score that hold APVO. The ETFs are listed according to market value of APVO within the ETF
---
---